Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) withdrew its full-year 2026 revenue guidance after second-quarter sales fell 4% and its net loss widened, with newly appointed Chief Executive Officer …
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) posted a 12.8% increase in second-quarter revenue as subscription sales and recurring revenue expanded, though operating margins narrowed from a year earlier …
Bentley Revenue Climbs 13% as Recurring Sales Expand Read More
WEST CHESTER, PA — QVC Group, Inc. (Nasdaq: QVCG) emerged from Chapter 11 this month after reducing debt by more than $5 billion and securing a $600 million asset-based lending …
QVC Cuts Debt by $5 Billion, Names Interim CEO Read More
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) received Fast Track designation from the U.S. Food and Drug Administration for modzatinib as a potential treatment for moderate to severe lichen …
FDA Fast Track Status Advances Aclaris Lichen Planus Drug Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported a $13.2 million second-quarter loss as total revenue fell sharply from a year earlier despite record demand and higher U.S. …
Verrica Revenue Falls Despite Record YCANTH Demand Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) extended its expected cash runway into 2028 with a $130 million convertible debt financing as the biotechnology company moves one retinal gene therapy …
Ocugen Raises $130 Million as Gene Therapy Trials Advance Read More WAYNE, PA — Aclaris Therapeutics Inc. (NASDAQ: ACRS) raised $40.2 million through an at-the-market stock sale after the second quarter, extending its expected cash runway through the end of 2028 …
Aclaris Raises Capital as Drug Pipeline Spending Accelerates Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) granted newly hired Chief Executive Officer Heather Getz stock options covering 2.37 million shares and restricted stock units covering another 500,000 shares, …
TELA Bio Grants New CEO Options on 2.37 Million Shares Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Executive Officer Wes Kaupinen will address investors Wednesday at the Canaccord Genuity 46th Annual Growth Conference as the clinical-stage biotechnology company …
Palvella CEO to Address Investors at Canaccord Conference Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) began its rolling U.S. application for QTORIN rapamycin during the second quarter as higher clinical, manufacturing and regulatory spending more than doubled …
Palvella Advances FDA Filing as Drug Spending Lifts Loss Read More